核受体系统对P540芳香化酶的调节作用
Regulative effects of nuclear receptor system on P450 aromatase
摘要
芳香化酶 (P4 5 0aromatase ,P4 5 0arom)作为体内雌激素生物合成的限速酶 ,主要分布于人体性腺、骨骼、脂肪和大脑等雌激素的靶器官。核受体及其配体在许多生物学领域中具有重要的生理作用和治疗应用价值 ,近期的研究发现核受体通过组织特异性P4 5 0arom启动子调节不同组织中芳香化酶的表达。
出处
《生殖医学杂志》
CAS
2004年第3期186-189,共4页
Journal of Reproductive Medicine
基金
国家自然科学基金项目 (3 0 170 44 4)
参考文献26
-
1Young M, Mcphaul MJ. A steroidogenic factor-1 binding site and cyclic adenosine 3',5' -monophosphate response element-like elements are required for the activity of the rat aromatase promoter in rat leydig tumor cell lines[J]. Endocrinology, 1998,139 (12)
-
2Carlone DL, Richards JS. Functional interactions,phosphorylation, and levels of 3',5'-cyclic adenosine monophosphate-regulatory element binding protein and steroidogenic factor-1 mediate hormone-regulated and consititutive expression of aromatase in gonad
-
3Micheal MD, Kilgore MW, Morohashi K , et al. Ad4BP/SF-1 regulates cyclic AMP-induced transcription from the proximal promoter(PII) of the human aromatase P450 (CYP19) gene in the ovary[J]. J Bio Chem,1995, 270(22): 13561-13566.
-
4Mu YM, Yanase T, Nishi Y, et al.Combined treatment with specific ligands for PPARγ:RAR nuclear receptor system markedly inhibits the expression of cytochrome P450 in human granulose cancer cells [J].Mol Cell Endocrinol,2001,181(1-2):239-248.
-
5Tanaka S, Haji M, Takayanagi R, et al. 1,25-Dihydroxyvitamin D3 enhances the enzymatic activity and expression of the messenger ribonucleic acid for aromatase cytochrome P450 synergistically with dexamethasone depending on the vitamin D receptor level in
-
6Zhao Y, Agarwal VR, Mendelson CR,et al. Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene[J]. Endocrinology,1996,137(12):5739-5742.
-
7Rubin GL, Zhao Y, Kalus AM, et al. Peroxisome proliferator-activated receptor gamma ligand inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy [J ].Cancer Res ,2000,60(6):1604-1608.
-
8Mu YM, Yanase T, Nishi Y, et al. A nuclear receptor system constituted by RAR and RXR induces aromatase activity in MCF-7 human breast cancer cells[J]. Mol Cell Edocr, 2000, 166(2): 137-145.
-
9Chen S, Zhou D, Yang C, et al. Modulation of aromatase expression in human breast tissue[J]. J Steroid Biochem Mol Bio, 2001,79(1-5):35-40.
-
10Simpson ER, Mahendrp MS,Means GD, et al. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis[J]. Endocr Rev, 1994, 15(3):342-355.
-
1张吉强,蔡文琴.脑内雌激素受体的研究进展[J].局解手术学杂志,2009,18(1):1-2. 被引量：11
-
2李明,马芳玲,母义明,汪保安,窦京涛,陆菊明,李江源,潘长玉.胰岛素增敏剂曲格列酮对人卵巢颗粒细胞芳香化酶活性的抑制作用[J].解放军医学杂志,2003,28(4):307-309. 被引量：1
-
3张浩,詹立,吴德生.壬基酚对围产期子代雄性SD大鼠性腺组织PCNA和AROMATASE表达的影响[J].四川大学学报（医学版）,2006,37(1):23-26. 被引量：2
-
4向华,廖清江.选择性雌激素受体调节剂有关药物的研究进展[J].中国药房,2001,12(9):561-563. 被引量：5
-
5胡骁,朱予津,袁鹏飞,吴丹,郭洪声,邓桂茹.选择性雌激素受体调节剂的合成研究进展[J].武警医学院学报,2005,14(2):151-156.
-
6朱嘉月,孙增荣,张颖,梁东春.邻苯二甲酸二丁酯对大鼠血清雌二醇水平的影响及其机制研究[J].环境与健康杂志,2010,27(1):30-32. 被引量：4
-
7李孟森,周升,李刚.选择性雌激素受体调节剂的作用机制及其治疗绝经后骨质疏松症的研究现状[J].中国临床药理学与治疗学,2008,13(2):213-219. 被引量：14
-
8徐婷燕,施仲伟.性激素替代治疗不能预防冠心病[J].中国医药导刊,2003,5(4):293-295.
-
9盛微,王校,王哲,那晓琳.大豆异黄酮和DEHP对雌性大鼠体内雌激素水平的影响[J].癌变．畸变．突变,2015,27(3):216-220. 被引量：4
-
10司玉昌,张婷婷,刘玮,郭洪声.选择性雌激素受体调节药研究进展[J].武警医学,2008,19(12):1133-1135.
